Showing 1 – 4 of 4 results.
Curated
Restricted
Arrestee Drug Abuse Monitoring II in the United States, 2012 (Restricted Use) (ICPSR 34821)
Released/updated on: 2013-08-29
Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)
Time period: 2012-04-30--2012-07-29
The Arrestee Drug Abuse Monitoring II, 2012 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2012 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2012 survey represents the sixth year of ADAM II and includes data from 1,938 interviews and 1,736 urine tests that were conducted at the five ADAM II sites over a 21-day period, between April 30 and July 29, 2012. The samples from these sites were weighted to represent over 14,000 arrests of adult males in the five counties. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.
Curated
Restricted
Arrestee Drug Abuse Monitoring II in the United States, 2013 (Restricted Use) (ICPSR 35169)
Released/updated on: 2014-08-01
Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)
Time period: 2013-05-05--2013-07-28
The Arrestee Drug Abuse Monitoring II, 2013 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2013 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2013 survey represents the seventh year of ADAM II and includes data from 1,900 interviews and 1,681 urine tests that were conducted at the five ADAM II sites over a 21-day period, between May 5, 2013 and July 28, 2013. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, citizenship, marital status, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.
Curated
Restricted
Health Consequences of Long-Term Injection Heroin Use Among Aging Mexican American Men in Houston, Texas, 2008 - 2011 [Restricted-use Files] (ICPSR 34896)
Released/updated on: 2015-01-21
Geographic coverage: United States, Texas
Time period: 2008-01-01--2011-01-01
The study is comprised of interviews from 227 Hispanic males aged 45 or older living in the area of Houston, Texas to address the gaps in knowledge on the social factors and health consequences of injection heroin use among aging Mexican American males. Specifically, the study investigated how the life course transitions of incarceration and drug treatment and drug abuse and family trajectories affect both the heroin career status and health consequences of these aging Mexican American men.
The study used a cross-sectional, field-intensive outreach methodology augmented with respondent-driven sampling. Recruitment was focused in two Houston neighborhoods that are predominantly Mexican American areas with high rates of crime, poverty, and psychosocial challenges. Trained Outreach Specialists familiar with these communities identified community gatekeepers and gained their trust through continued presence in the community and ongoing dialogue about the study. These gatekeepers then helped identify individuals meeting the inclusion criteria: Mexican American men aged 45 years or older with a history of injection drug use for at least 3 years. The men were then classified into one of three groups: current injectors (current group), former injectors not in treatment (former group), or former injectors currently enrolled in methadone maintenance treatment programs (MMTP group).
The second part is a second survey asking questions about social networks the respondent participates in. Questions ask the respondent to answer on one individual in their network and answer questions about that person and their interaction with them. Questions include basic demographics, history injecting drugs and sexual contact with the person.
Curated
Treatment of Incarcerated Women with Substance Use Disorder and Post-traumatic Stress Disorder in Providence, Rhode Island, 1999-2001 (ICPSR 3416)
Released/updated on: 2005-11-04
Geographic coverage: Rhode Island, United States
Time period: 1999-10-01--2001-11-30
The goal of this study was to evaluate the initial efficacy, feasibility, and acceptability of Seeking Safety (SS) treatment in a sample of incarcerated women with comorbid substance use disorder (SUD) and comorbid post-traumatic stress disorder (PTSD). Seeking Safety, a cognitive-behavioral psychotherapy treatment, is a psychosocial treatment for women with comorbid PTSD and SUD and, at the time this study was conducted, it was the treatment with the most efficacy data for this population. SS treatment appears to be a promising intervention for incarcerated women with PTSD and SUD because (1) the treatment targets many of the deficits found in this population that may interfere with their recovery and place these women at risk for reoffending (such as impulsiveness, anger dyscontrol, and maladaptive lifestyle activities), and (2) it teaches skills to manage these problematic behaviors. This study aimed to conduct an open feasibility trial of Seeking Safety treatment in a sample of six incarcerated women with SUD and PTSD and to conduct a randomized controlled pilot study to evaluate the initial efficacy, feasibility, and acceptability of the proposed treatment as an adjunct to treatment as usual (TAU), compared to a TAU control group in a sample of 22 incarcerated women with comorbid PTSD and SUD. The primary hypothesis was that, compared to the TAU condition, women in the SS treatment condition would have less severe drug and alcohol use as well as fewer PTSD symptoms and legal problems after intervention, and at six weeks and three months after release. The first six participants recruited for the study received SS group treatment as an adjunct to the treatment provided by the Discovery Program, the substance abuse treatment program in the minimum security arm of the Women's Facility of the Adult Correctional Institution in Providence, Rhode Island. The remaining participants were randomly assigned to either the control group (TAU) or to a group that received SS treatment as an adjunct to TAU. The treatment groups were conducted by clinicians who worked as substance abuse therapists in the Discovery Program and a clinical psychologist from Brown University. All SS therapists received training in delivering SS therapy from Dr. Lisa Najavits, who developed SS treatment. Assessments were conducted at pretreatment, post-treatment during incarceration, and three and six months postrelease for PTSD-related measures. Measures of severity of substance abuse and legal problems were taken at pretreatment, as well as at the six- and 12-week postrelease intervals. Measures were taken with a variety of clinical instruments, including the Addiction Severity Index (ASI), the Structured Clinical Interview for DSM-IV (SCID) module on substance use, the Clinician Administered Post-Traumatic Stress Disorder Scale-I (CAPS-I), the Trauma History Questionnaire (THQ), the Helping Alliance Questionnaire-II (HAQ-II), the Client Satisfaction Questionnaire, and the End-of-Treatment Questionnaire. Basic demographic data were also collected from administrative records. Variables include alcohol, drug, and legal composite scores at pretreatment and post-treatment, number of relapses, whether the woman returned to prison, whether the woman lied about substance abuse, use of particular substances one month prior to prison and during lifetime, PTSD indicators of frequency and intensity, total client satisfaction scores, patients' ratings of therapists and treatment, and trauma scales for crime, sexual abuse, and physical abuse. Demographic variables include age, ethnic background, education, first time in prison, the nature of the current conviction, and number of arrests with convictions.